Central Drugs Standard Control Organization
-
CDSCO gives nod to Rakuten Medical to start phase 3 trial for cancer drug
The multi-centre, randomised, open-label, global Phase 3 study of Alluminox treatment using ASP-1929 will evaluate the efficacy and safety of…
Read More » -
MSN Labs enters into licensing agreement with Lilly
Baricitinib (BARIDOZ) will be launched in India for COVID-19 treatment MSN Labs has entered into a royalty-free, non-exclusive, voluntary license…
Read More » -
COVID 19 – Baxter India gets CDSCO Nod for Oxiris Filter to Treat COVID-19 Patients
Central Drugs Standard Control Organization (CDSCO) has approved Baxter India under Directorate General of Health Services, Ministry of Health &…
Read More »
